CoChat

Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐ and NF‐κB‐dependent pathways

Open access
El‐Hashim, Ahmed Z, Renno, Waleed M, Raghupathy, Raj, Abduo, Heba T, Akhtar, Saghir, Benter, Ibrahim F · 2012 · British Journal of Pharmacology
Cited by 154

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE Angiotensin‐(1–7) [Ang‐(1–7)] has anti‐inflammatory effects in models of cardiovascular disease and arthritis, but its effects in asthma are unknown. We investigated whether Ang‐(1–7) has anti‐inflammatory actions in a murine model of asthma. EXPERIMENTAL APPROACH The effects of Ang‐(1–7) alone or in combination with the MAS1 receptor antagonist, A779, were evaluated over a 4 day period in an ovalbumin‐challenged mouse model of allergic asthma. On day 5, bronchoalveolar lavage was performed, and lungs were sectioned and assessed histologically for quantification of goblet cells, perivascular and peribronchial inflammation and fibrosis. Biochemical analysis of the pro‐inflammatory ERK1/2 and IκB‐α was assessed. In addition, the effect of Ang‐(1–7) on proliferation of human peripheral blood mononuclear cells (HPBMC) was investigated. KEY RESULTS Ang‐(1–7) attenuated ovalbumin‐induced increases in total cell counts, eosinophils, lymphocytes and neutrophils. Ang‐(1–7) also decreased the ovalbumin‐induced perivascular and peribronchial inflammation, fibrosis and goblet cell hyper/metaplasia. Additionally, Ang‐(1–7) reduced the ovalbumin‐induced increase in the phosphorylation of ERK1/2 and IκB‐α. These effects of Ang‐(1–7) were reversed by the MAS1 receptor antagonist A779. Furthermore, Ang‐(1–7) inhibited phytohaemagglutinin (PHA)‐induced HPBMC proliferation. CONCLUSION AND IMPLICATIONS Ang‐(1–7), via its MAS1 receptor, acts as an anti‐inflammatory pathway in allergic asthma, implying that activation of the MAS1 receptor may represent a novel approach to asthma therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2012.01905.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 154

Metadata

Authors
El‐Hashim, A. Z., Renno, W. M., Raghupathy, R., Abduo, H. T., Akhtar, S., & Benter, I. F.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2012-06-27
Volume
166
Issue
6
Pages
1964-1976
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1493720279
Cited by
154
References
2
FWCI
6.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐ and NF‐κB‐dependent pathways. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.01905.x
The paper
El‐Hashim, A. Z., Renno, W. M., Raghupathy, R., Abduo, H. T., Akhtar, S., & Benter, I. F. (2012). Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐ and NF‐κB‐dependent pathways. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.01905.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.